Zacks Investment Research upgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a buy rating in a research note published on Wednesday, Zacks.com reports. The firm currently has $89.00 price objective on the real estate investment trust’s stock.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
NHI stock traded up $0.17 during trading on Wednesday, reaching $80.01. 194,979 shares of the company were exchanged, compared to its average volume of 168,994. The business’s 50-day moving average is $79.33. The company has a market capitalization of $3.46 billion, a P/E ratio of 14.60, a price-to-earnings-growth ratio of 3.61 and a beta of 0.37. National Health Investors has a twelve month low of $70.54 and a twelve month high of $84.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 14.99 and a quick ratio of 14.99.
National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.31 by ($0.48). The company had revenue of $76.11 million for the quarter, compared to analyst estimates of $73.21 million. National Health Investors had a return on equity of 10.96% and a net margin of 50.87%. National Health Investors’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.35 earnings per share. As a group, research analysts forecast that National Health Investors will post 5.5 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, June 28th will be given a dividend of $1.05 per share. This represents a $4.20 dividend on an annualized basis and a yield of 5.25%. The ex-dividend date is Thursday, June 27th. National Health Investors’s dividend payout ratio is 76.64%.
A number of hedge funds have recently added to or reduced their stakes in NHI. Marshall Wace North America L.P. bought a new stake in National Health Investors during the 1st quarter worth approximately $31,000. Farmers National Bank bought a new stake in National Health Investors during the 1st quarter worth approximately $49,000. Quadrant Capital Group LLC grew its holdings in National Health Investors by 306.7% during the 1st quarter. Quadrant Capital Group LLC now owns 793 shares of the real estate investment trust’s stock worth $61,000 after acquiring an additional 598 shares during the last quarter. Brinker Capital Inc. bought a new stake in National Health Investors during the 1st quarter worth approximately $202,000. Finally, Quantamental Technologies LLC grew its holdings in National Health Investors by 200.6% during the 1st quarter. Quantamental Technologies LLC now owns 2,997 shares of the real estate investment trust’s stock worth $235,000 after acquiring an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 69.98% of the company’s stock.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: Why do companies pay special dividends?
Get a free copy of the Zacks research report on National Health Investors (NHI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.